U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy

The U.S. Trump administration is preparing to send Ebola-exposed American citizens to Kenya for quarantine and treatment, abandoning the previous practice of repatriating them to specialized U.S. medical units. A facility in Kenya will be established through collaboration between the Departments of State, Defense, and Health and Human Services, with a few dozen Public Health Service officers set to deploy to provide care. The decision follows the DRC’s Ebola outbreak surpassing 1,000 cases as of May 26, 2026, with over 200 deaths reported. Initially, the plan involved monitoring Americans in Kenya before transferring symptomatic individuals to Europe for treatment. However, the administration now intends to provide treatment on-site in Kenya, including for government scientists and physicians who develop symptoms. Advanced care needs will be assessed case-by-case, though experts question whether Kenya’s facilities can match the U.S. standards for handling Ebola, which has an 80-90% death rate without timely, specialized care. This approach contrasts with past administrations, which repatriated exposed citizens for treatment in high-level U.S. medical units, such as the Omaha facility currently monitoring 18 Americans for hantavirus. Earlier this month, the administration flew an American aid doctor with symptoms to Germany and sent six others to Germany and the Czech Republic for monitoring. The shift aligns with a recent public health law invocation banning immigrants and legal permanent residents from Congo, Uganda, or South Sudan—who had been in those countries in the past 21 days—from entering the U.S. Critics, including Dr. Tom Inglesby of Johns Hopkins Center for Health Security, argue the policy reflects an ethical failure, as U.S. facilities are better equipped to handle Ebola. Dr. Craig Spencer, a Brown University public health expert who survived Ebola in 2014, called the move ‘a dramatic abdication of what we owe our own.’ Early access to high-quality care significantly improves survival odds, he emphasized. The CDC reports Ebola’s high fatality rate underscores the urgency of specialized treatment. While Kenya’s facilities may be superior to those in Congo, experts doubt they can replicate the decade-long U.S. infrastructure designed for such outbreaks. The administration’s decision raises concerns about prioritizing containment over ethical obligations to affected citizens.